Structural modeling of ataxin-3 reveals distant homology to adaptins

Proteins: Structure, Function and Genetics

Volumn 50, Issue 2, 2003, Pages 355-370

  Albrecht, Mario ^a   Hoffmann, Daniel ^b   Evert, Bernd O ^c   Schmitt, Ina ^c   Wüllner, Ullrich ^c   Lengauer, Thomas ^d  

^a FRAUNHOFER INSTITUTE FOR ALGORITHMS AND SCIENTIFIC COMPUTING SCAI   (Germany)

^b CENTER OF ADVANCED EUROPEAN STUDIES AND RESEARCH CAESAR   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

Author keywords

AP180; Ataxin 3; ENTH; Josephin; SCA3 MJD; Structure prediction; UIM; VHS

Indexed keywords

ADAPTIN PROTEIN; ADAPTOR PROTEIN; ATAXIN 3 PROTEIN; JOSEPHIN PROTEIN; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; MATHEMATICAL ANALYSIS; MEMBRANE TRANSPORT; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; RELIABILITY; SEQUENCE HOMOLOGY;

ADAPTOR PROTEIN COMPLEX GAMMA SUBUNITS; AMINO ACID SEQUENCE; ANIMALS; CONSERVED SEQUENCE; DATABASES, PROTEIN; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; REPRESSOR PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; STRUCTURE-ACTIVITY RELATIONSHIP;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0037297592     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/prot.10280     Document Type: Article

References (185)

1. Cummings CJ, Zoghbi HY. Trinucleotide repeats: Mechanisms and pathophysiology. Annu Rev Genomics Hum Genet 2000;1:281-328.
2. Dürr A, Stevanin G, Cancel G, Duyckaerts C, Abbas N, Didierjean O, Chneiweiss H, Benomar A, Lyon-Caen O, Julien J, et al. Spinocerebellar ataxia 3 and Machado-Joseph disease: Clinical, molecular, and neuropathological features. Ann Neurol 1996;39:490-499.
3. Ranum LP, Lundgren JK, Schut LJ, Ahrens MJ, Perlman S, Aita J, Bird TD, Gomez C, Orr HT. Spinocerebellar ataxia type 1 and Machado-Joseph disease: Incidence of CAG expansions among adult-onset ataxia patients from 311 families with dominant, recessive, or sporadic ataxia. Am J Hum Genet 1995;57:603-608.
4. Schols L, Vieira-Saecker AM, Schols S, Przuntek H, Epplen JT, Riess O. Trinucleotide expansion within the MJD1 gene presents clinically as spinocerebellar ataxia and occurs most frequently in german SCA patients. Hum Mol Genet 1995;4:1001-1005.
5. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, Kawakami H, Nakamura S, Nishimura M, Akiguchi I, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 1994;8:221-228.
6. Paulson HL, Das SS, Crino PB, Perez MK, Patel SC, Gotsdiner D, Fischbeck KH, Pittman RN. Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Ann Neurol 1997;41:453-462.
7. Trottier Y, Cancel G, An-Gourfinkel I, Lutz Y, Weber C, Brice A, Hirsch E, Mandel JL. Heterogeneous intracellular localization and expression of ataxin-3. Neurobiol Dis 1998;5:335-347.
8. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, Moqrich A, et al. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 2002;99:4465-4470.
9. Ichikawa Y, Goto J, Hattori M, Toyoda A, Ishii K, Jeong SY, Hashida H, Masuda N, Ogata K, Kasai F, et al. The genomic structure and expression of MJD, the Machado-Joseph disease gene. J Hum Genet 2001;46:413-422.
10. Evert BO, Wüllner U, Klockgether T. Cell death in polyglutamine diseases. Cell Tissue Res 2000;301:189-204.
11. Klockgether T, Wüllner U, Spauschus A, Evert B. The molecular biology of the autosomal-dominant cerebellar ataxias. Mov Disord 2000;15:604-612.
12. Zoghbi HY, Orr HT. Glutamine repeats and neurodegeneration. Annu Rev Neurosci 2000;23:217-247.
13. Cummings CJ, Zoghbi HY. Fourteen and counting: Unraveling trinucleotide repeat diseases. Hum Mol Genet 2000;9:909-916.
14. Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, Hasenbank R, Bates GP, Davies SW, Lehrach H, Wanker EE. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 1997;90:549-558.
15. Paulson HL. Toward an understanding of polyglutamine neurodegeneration. Brain Pathol 2000;10:293-299.
16. Gusella JF, MacDonald ME. Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease. Nat Rev Neurosci 2000;1:109-115.
17. Ikeda H, Yamaguchi M, Sugai S, Aze Y, Narumiya S, Kakizuka A. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nat Genet 1996;13:196-202.
18. Cemal CK, Carroll CJ, Lawrence L, Lowrie MB, Ruddle P, Al-Mahdawi S, King RH, Pook MA, Huxley C, Chamberlain S. YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit. Hum Mol Genet 2002;11:1075-1094.
19. Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS, Vig P, Mandel JL, Fischbeck KH, Pittman RN. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 1997;19:333-344.
20. Evert BO, Wiillner U, Schulz JB, Weller M, Groscurth P, Trottier Y, Brice A, Klockgether T. High level expression of expanded full-length ataxin-3 in vitro causes cell death and formation of intranuclear inclusions in neuronal cells. Hum Mol Genet 1999;8:1169-1176.
21. Uchihara T, Fujigasaki H, Koyano S, Nakamura A, Yagishita S, Iwabuchi K. Nonexpanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias - Triple-labeling immunofluorescence study. Acta Neuropathol (Berl) 2001;102:149-152.
22. Evert BO, Vogt IR, Kindermann C, Ozimek L, de Vos RA, Brunt ER, Schmitt I, Klockgether T, Wüllner U. Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains. J Neurosci 2001;21:5389-5396.
23. Chan HY, Warrick JM, Gray-Board GL, Paulson HL, Bonini NM. Mechanisms of chaperone suppression of polyglutamine disease: Selectivity, synergy and modulation of protein solubility in drosophila. Hum Mol Genet 2000;9:2811-2820.
24. Paulson HL, Bonini NM, Roth KA. Polyglutamine disease and neuronal cell death. Proc Natl Acad Sci USA 2000;97:12957-12958.
25. Chai Y, Koppenhafer SL, Shoesmith SJ, Perez MK, Paulson HL, Evidence for proteasome involvement in polyglutamine disease: Localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum Mol Genet 1999;8:673-682.
26. Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 2001;292:1552-1555.
27. Schmidt T, Lindenberg KS, Krebs A, Schols L, Laccone F, Herms J, Rechsteiner M, Riess O, Landwehrmeyer GB. Protein surveillance machinery in brains with spinocerebellar ataxia type 3: Redistribution and differential recruitment of 26s proteasome subunits and chaperones to neuronal intranuclear inclusions. Ann Neurol 2002;51:302-310.
28. Paulson HL. Protein fate in neurodegenerative proteinopathies: Polyglutamine diseases join the (mis)fold. Am J Hum Genet 1999;64:339-345.
29. Perutz MF. Glutamine repeats and neurodegenerative diseases: Molecular aspects. Trends Biochem Sci 1999;24:58-63.
30. Perutz MF, Windle AH. Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats. Nature 2001;412:143-144.
31. Harper JD, Lansbury PTJ. Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 1997;66:385-407.
32. Harper JD, Wong SS, Lieber CM, Lansbury PTJ. Assembly of A beta amyloid protofibrils: An in vitro model for a possible early event in alzheimer's disease. Biochemistry 1999;38:8972-8980.
33. Taylor JP, Hardy J, Fischbeck KH. Toxic proteins in neurodegenerative disease. Science 2002;296:1991-1995.
34. Bevivino AE, Loll PJ. An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel β-fibrils. Proc Natl Acad Sci USA 2001;98:11955-11960.
35. Perutz MF, Finch JT, Berriman J, Lesk A. Amyloid fibers are water-filled nanotubes. Proc Natl Acad Sci USA 2002;99:5591-5595.
36. Perutz MF, Pope BJ, Owen D, Wanker EE, Scherzinger E. Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid beta-peptide of amyloid plaques. Proc Natl Acad Sci USA 2002;99:5596-5600.
37. Chen S, Berthelier V, Hamilton JB, O'Nuallain B, Wetzel R. Amyloid-like features of polyglutamine aggregates and their assembly kinetics. Biochemistry 2002;41:7391-7399.
38. Bairoch A, Apweiler R. The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. Nucleic Acids Res 2000;28:45-48.
39. Bader GD, Donaldson I, Wolting C, Ouellette BF, Pawson T, Hogue CW. BIND: the biomolecular interaction network database. Nucleic Acids Res 2001;29:242-245.
40. Costanzo MC, Crawford ME, Hirschman JE, Kranz JE, Olsen P, Robertson LS, Skrzypek MS, Braun BR, Hopkins KL, Kondu P, et al. YPD, PombePD and WormPD: Model organism volumes of the BioKnowledge Library, an integrated resource for protein information. Nucleic Acids Res 2001;29:75-79.
41. Gavin AC, Bosche M, Krause R, Grandi P, Marzioch M, Bauer A, Schultz J, Rick JM, Michon AM, Cruciat CM, et al. Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 2002;415:141-147.
42. Ho Y, Gruhler A, Heilbut A, Bader GD, Moore L, Adams SL, Millar A, Taylor P, Bennett, K, Boutilier K, et al. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 2002;415:180-183.
43. Mewes HW, Frishman D, Guldener U, Mannhaupt G, Mayer K, Mokrejs M, Morgenstern B, Munsterkotter M, Rudd S, Weil B. MIPS: A database for genomes and protein sequences. Nucleic Acids Res 2002;30:31-34.
44. Goto J, Watanabe M, Ichikawa Y, Yee SB, Ihara N, Endo K, Igarashi S, Takiyama Y, Gaspar, C, Maciel P, et al. Machado-Joseph disease gene products carrying different carboxyl termini. Neurosci Res 1997;28:373-377.
45. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data Bank. Nucleic Acids Res 2000;28:235-242.
46. Holm L, Sander C. Mapping the protein universe. Science 1996;273:595-602.
47. Holm L, Sander C. Protein structure comparison by alignment of distance matrices. J Mol Biol 1993;233:123-138.
48. Murzin AG, Brenner SE, Hubbard T, Chothia C. SCOP: A structural classification of proteins database for the investigation of sequences and structures. J Mol Biol 1995;247:536-540.
49. Conte LL, Brenner SE, Hubbard TJP, Chothia C, Murzin AG. SCOP database in 2002: Refinements accommodate structural genomics. Nucleic Acids Res 2002;30:264-267.
50. Kabsch W, Sander C. Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983;22:2577-2637.
51. Bateman A, Birney E, Cerruti L, Durbin R, Etwiller L, Eddy SR, Griffiths-Jones S, Howe KL, Marshall M, Sonnhammer ELL. The Pfam protein families database. Nucleic Acids Res 2002;30:276-280.
52. Schultz J, Milpetz F, Bork P, Ponting CP. SMART, a simple modular architecture research tool: Identification of signaling domains. Proc Natl Acad Sci USA 1998;95:5857-5864.
53. Letunic I, Goodstadt L, Dickens NJ, Doerks T, Schultz J, Mott R, Ciccarelli F, Copley RR, Ponting CP, Bork P. Recent improvements to the SMART domain-based sequence annotation resource. Nucleic Acids Res 2002;30:242-244.
54. Corpet F, Servant F, Gouzy J, Kahn D. ProDom and ProDom-CG: Tools for protein domain analysis and whole genome comparisons. Nucleic Acids Res 2000;28:267-269.
55. Apweiler R, Attwood TK, Bairoch A, Bateman A, Birney E, Biswas M, Bucher P, Cerutti L, Corpet F, Croning MD, et al. The InterPro database, an integrated documentation resource for protein families, domains and functional sites. Nucleic Acids Res 2001;29:37-40.
56. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990;215:403-410.
57. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 1997;25:3389-3402.
58. Pearson WR, Lipman DJ. Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 1988;85(8):2444-2448.
59. Pearson WR. Empirical statistical estimates for sequence similarity searches. J Mol Biol 1998;276:71-84.
60. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
61. Higgins DG, Thompson JD, Gibson TJ. Using CLUSTAL for multiple sequence alignments. In: Doolittle RF, editor. Methods in Enzymology, vol 266. San Diego: Academic Press; 1996. p 383-402.
62. Shindyalov IN, Bourne PE. Protein structure alignment by incremental combinatorial extension (CE) of the optimal path. Protein Eng 1998;11:739-747.
63. Bujnicki JM, Elofsson A, Fischer D, Rychlewski L. Structure prediction meta server. Bioinformatics 2001;17(8):750-751.
64. Falquet L, Pagni M, Bucher P, Hulo N, Sigrist CJ, Hofmann K, Bairoch A. The PROSITE database, its status in 2002. Nucleic Acids Res 2002;30:235-238.
65. Nakai K, Kanehisa M. A knowledge base for predicting protein localization sites in eukaryotic cells. Genomics 1992;14:897-911.
66. Horten P, Nakai K. A probabilistic classification system for predicting the cellular localization sites of proteins. Proc Int Conf Intell Syst Mol Biol, 1996;4:109-115.
67. Horten P, Nakai K. Better prediction of protein cellular localization sites with the k nearest neighbors classifier. Proc Int Conf Intell Syst Mol Biol 1997;5:147-152.
68. Baldi P, Brunak S, Frasconi P, Soda G, Pollastri G, Exploiting the past and the future in protein secondary structure prediction. Bioinformatics 1999;15:937-946.
69. Pollastri G, Przybylski D, Rost B, Baldi P. Improving the prediction of protein secondary structure in three and eight classes using recurrent neural networks and profiles. Proteins 2002;47:228-235.
70. Karplus K, Barrett C, Hughey R. Hidden Markov models for detecting remote protein homologies. Bioinformatics 1998;14:846-856.
71. Karplus K, Barrett C, Cline M, Diekhans M, Grate L, Hughey R. Predicting protein structure using only sequence information. Proteins 1999;37(Suppl 3):121-125.
72. Rost B, Eyrich VA. EVA: Large-scale analysis of secondary structure prediction. Proteins 2001;45(Suppl 5):192-199.
73. Lupas A, van Dyke M, Stock J. Predicting coiled coils from protein sequences. Science 1991;252:1162-1164.
74. Lupas A. Prediction and analysis of coiled-coil structures. In: Doolittle RF, editor. Methods in Enzymology, vol 266. San Diego: Academic Press; 1996. p 513-525.
75. Berger B, Wilson DB, Wolf E, Tonchev T, Milla M, Kim PS. Predicting coiled coils by use of pairwise residue correlations. Proc Natl Acad Sci USA 1995;92:8259-8263.
76. Wolf E, Kim PS, Berger B. Multicoil: A program for predicting two- and three-stranded coiled coils. Protein Sci 1997;6:1179-1189.
77. Grum VL, Li D, MacDonald RI, Mondragon A. Structures of two repeats of spectrin suggest models of flexibility. Cell 1999;98:523-535.
78. Djinovic-Carugo K, Gautel M, Ylänne J, Young P. The spectrin repeat: A structural platform for cytoskeletal protein assemblies. FEBS Lett 2002;513:119-123.
79. Vriend G. WHAT IF: A molecular modeling and drug design program. J Mol Graph 1990;8:52-56.
80. Rodriguez R, Chinea G, Lopez N, Pons T, Vriend G. Homology modeling, model and software evaluation: Three related resources. Bioinformatics 1998;14:523-528.
81. Nicholls A, Sharp KA, Honig B. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 1990;11:281-296.
82. Schmitt I, Brattig T, Gossen M, Riess O. Characterization of the rat spinocerebellar ataxia type 3 gene. Neurogenetics 1997;1:103-112.
83. Linhartova I, Repitz M, Draber P, Nemec M, Wiche G, Propst F. Conserved domains and lack of evidence for polyglutamine length polymorphism in the chicken homolog of the Machado-Joseph disease gene product ataxin-3. Biochim Biophys Acta 1999;1444:299-305.
84. Hofmann K, Falquet L. A ubiquitin-interacting motif conserved in components of the proteasomal and lysosomal protein degradation systems. Trends Biochem Sci 2001;26:347-350.
85. Wang G, Sawai N, Kotliarova S, Kanazawa I, Nukina N. Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B. Hum Mol Genet 2000;9:1795-1803.
86. Wendland B, Steece KE, Emr SD. Yeast epsins contain an essential N-terminal ENTH domain, bind clathrin and are required for endocytosis. EMBO J 1999;18:4383-4393.
87. Watson HA, Cope MJ, Groen AC, Drubin DG, Wendland B. In vivo role for actin-regulating kinases in endocytosis and yeast epsin phosphorylation. Mol Biol Cell 2001;12:3668-3679.
88. Misra S, Beach BM, Hurley JH. Structure of the VHS domain of human Tom1 (target of myb 1): Insights into interactions with proteins and membranes. Biochemistry 2000;39:11282-11290.
89. Koshiba S, Kigawa T, Kikuchi A, Yokoyama S. Solution structure of the epsin N-terminal homology (ENTH) domain of human epsin. J Struct Funct Genom 2001;2:1-8.
90. Misra S, Hurley JH. Crystal structure of a phosphatidylinositol 3-phosphate-specific membrane-targeting motif, the FYVE domain of Vps27p. Cell 1999;97:657-666.
91. Gerrard SR, Bryant NJ, Stevens TH. VPS21 controls entry of endocytosed and biosynthetic proteins into the yeast prevacuolar compartment. Mol Biol Cell 2000;11:613-626.
92. McMahon HT. Endocytosis: An assembly protein for clathrin cages. Curr Biol 1999;9:R332-R335.
93. Kay BK, Yamabhai M, Wendland B, Emr SD. Identification of a novel domain shared by putative components of the endocytic and cytoskeletal machinery. Protein Sci 1999;8:435-438.
94. Lohi O, Lehto VP. VHS domain marks a group of proteins involved in endocytosis and vesicular trafficking. FEBS Lett 1998;440:255-257.
95. Dell'Angelica EC. Clathrin-binding proteins: Got a motif? join the network Trends Cell Biol 2001;11:315-318.
96. Santolini E, Salcini AE, Kay BK, Yamabhai M, Di Fiore PP. The EH network. Exp Cell Res 1999;253:186-209.
97. Boehm M, Bonifacino JS. Adaptins: The final recount. Mol Biol Cell 2001;12:2907-2920.
98. Robinson MS, Bonifacino JS. Adaptor-related proteins. Curr Opin Cell Biol 2001;13:444-453.
99. Confalonieri S, Di Fiore PP. The Eps15 homology (EH) domain. FEBS Lett 2002;513:24-29.
100. De Camilli P, Chen H, Hyman J, Panepucci E, Bateman A, Brunger AT. The ENTH domain. FEBS Lett 2002;513:11-18.
101. Lohi O, Poussu A, Mao Y, Quiocho F, Lehto VP. VHS domain: A longshoreman of vesicle lines. FEBS Lett 2002;513:19-23.
102. Itoh T, Takenawa T. Phosphoinositide-binding domains. Functional units for temporal and spatial regulation of intracellular signalling. Cell Signal 2002;14:733-743.
103. Kirchhausen T. Single-handed recognition of a sorting traffic motif by the GGA proteins. Nat Struct Biol 2002;9:241-244.
104. 2+ finger protein (PLZF). J Cell Biol 2000;149:537-546.
105. 2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes. Science 2001;291:1051-1055.
106. Itoh T, Koshiba S, Kigawa T, Kikuchi A, Yokoyama S, Takenawa T. Role of the ENTH domain in phosphatidylinositol-4,5-bisphosphate binding and endocytosis. Science 2001;291:1047-1051.
107. Mao Y, Chen J, Maynard JA, Zhang B, Quiocho FA. A novel all helix fold of the AP180 amino-terminal domain for phosphoinositide binding and clathrin assembly in synaptic vesicle endocytosis. Cell 2001;104:433-440.
108. Dell'Angelica EC, Puertollano R, Mullins C, Aguilar RC, Vargas JD, Hartnell LM, Bonifacino JS. GGAs: A family of ADP ribosylation factor-binding proteins related to adaptors and associated with the Golgi complex. J Cell Biol 2000;149:81-94.
109. Misra S, Puertollano R, Kato Y, Bonifacino JS, Hurley JH. Structural basis for acidic-cluster-dileucine sorting-signal recognition by VHS domains. Nature 2002;415:933-937.
110. Shiba T, Takatsu H, Nogi T, Matsugaki N, Kawasaki M, Igarashi N, Suzuki M, Kato R, Earnest T, Nakayama K, Wakatsuki S. Structural basis for recognition of acidic-cluster dileucine sequence by GGA1. Nature 2002;415:937-941.
111. Mao Y, Nickitenko A, Duan X, Lloyd TE, Wu MN, Bellen H, Quiocho FA. Crystal structure of the VHS and FYVE tandem domains of Hrs, a protein involved in membrane trafficking and signal transduction. Cell 2000;100:447-456.
112. Shih SC, Katzmann DJ, Schnell JD, Sutanto M, Emr SD, Hicke L. Epsins and Vps27p/Hrs contain ubiquitin-binding domains that function in receptor endocytosis. Nat Cell Biol 2002;4:389-393.
113. Polo S, Sigismund S, Faretta M, Guidi M, Capua MR, Bossi G, Chen H, De Camilli P, Di Fiore PP. A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins. Nature 2002;416:451-455.
114. Raiborg C, Bache KG, Gillooly DJ, Madshus IH, Stang E, Stenmark H. Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early endosomes. Nat Cell Biol 2002;4:394-398.
115. Black MW, Pelham HR. Membrane traffic: How do GGAs fit in with the adaptors? Curr Biol 2001;11:R460-R462.
116. Boman AL. GGA proteins: New players in the sorting game. J Cell Sci 2001;114(Pt 19):3413-3418.
117. Mullins C, Bonifacino JS. The molecular machinery for lysosome biogenesis. BioEssays 2001;23:333-343.
118. Tooze SA. Cell biology. GGAs tie up the loose ends. Science 2001;292:1663-1665.
119. Driscoll PC. Solving the FYVE domain-PtdIns(3)P puzzle. Nat Struct Biol 2001;8:287-290.
120. Stenmark H, Aasland R, Driscoll PC. The phosphatidylinositol 3-phosphate-binding FYVE finger. FEBS Lett 2002;513:77-84.
121. Bradbury AF, Smyth DG. Biosynthesis of the C-terminal amide in peptide hormones. Biosci Rep 1987;7:907-916.
122. Bradbury AF, Smyth DG. Peptide amidation. Trends Biochem Sci 1991;16:112-115.
123. Kalthoff C, Alves J, Urbanke C, Knorr R, Ungewickell EJ. Unusual structural organization of the endocytic proteins AP180 and epsin 1. J Biol Chem 2001;277:8209-8216.
124. Wright PE, Dyson HJ. Intrinsically unstructured proteins: Reassessing the protein structure-function paradigm. J Mol Biol 1999;293:321-331.
125. Dyson HJ, Wright PE. Coupling of folding and binding for unstructured proteins. Curr Opin Struct Biol 2002;12:54-60.
126. Grishin NV. Fold change in evolution of protein structures. J Struct Biol 2001;134:167-185.
127. Perutz MF, Johnson T, Suzuki M, Finch JT. Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci USA 1994;91:5355-5358.
128. Perutz M. Polar zippers: Their role in human disease. Protein Sci 1994;3:1629-1637.
129. Perutz MF. Glutamine repeats and inherited neurodegenerative diseases: Molecular aspects. Curr Opin Struct Biol 1996;6:848-858.
130. Bennett MJ, Choe S, Eisenberg D. Domain swapping: Entangling alliances between proteins. Proc Natl Acad Sci USA 1994;91:3127-3131.
131. Bennett MJ, Schlunegger MP, Eisenberg D. 3D domain swapping: A mechanism for oligomer assembly. Protein Sci 1995;4:2455-2468.
132. Heringa J, Taylor WR. Three-dimensional domain duplication, swapping and stealing. Curr Opin Struct Biol 1997;7:416-421.
133. Schlunegger MP, Bennett MJ, Eisenberg D. Oligomer formation by 3D domain swapping: A model for protein assembly and misassembly. In: Richards, FM, Eisenberg DS, Kim PS, editors. Advances in Protein Chemistry, vol 50. San Diego: Academic Press; 1997. p 61-122.
134. Liu Y, Eisenberg D. 3D domain swapping: As domains continue to swap. Protein Sci 2002;11:1285-1299.
135. Newcomer ME. Protein folding and three-dimensional domain swapping: A strained relationship? Curr Opin Struct Biol 2002;12:48-53.
136. Chen YW, Stott K, Perutz MF. Crystal structure of a dimeric chymotrypsin inhibitor 2 mutant containing an inserted glutamine repeat. Proc Natl Acad Sci USA 1999;96:1257-1261.
137. Liu Y, Hart PJ, Schlunegger MP, Eisenberg D. The crystal structure of a 3D domain-swapped dimer of RNase A at a 2.1-Å resolution. Proc Natl Acad Sci USA 1998;95:3437-3442.
138. Liu Y, Gotte G, Libonati M, Eisenberg D. A domain-swapped RNase A dimer with implications for amyloid formation. Nat Struct Biol 2001;8:211-214.
139. Liu Y, Gotte G, Libonati M, Eisenberg D. Structures of the two 3D domain-swapped RNase A trimers. Protein Sci 2002;11:371-380.
140. Zhang Z, Weed SA, Gallagher PG, Morrow JS. Dynamic molecular modeling of pathogenic mutations in the spectrin self-association domain. Blood 2001;98:1645-1653.
141. Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell JEJ, Kuriyan J. Crystal structure ofa tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 1998;93:827-839.
142. Becker S, Groner B, Müller CW. Three-dimensional structure of the Stat3β homodimer bound to DNA. Nature 1998;394:145-151.
143. Vinkemeier U, Moarefi I, Darnell Jr, JE, Kuriyan J. Structure of the amino-terminal protein interaction domain of STAT-4. Science 1998;279:1048-1052.
144. Chatterjee-Kishore M, van den Akker F, Stark GR. Association of STATs with relatives and friends. Trends Cell Biol 2000;10:106-111.
145. Horvath CM. STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci 2000;25:496-502.
146. Jove R, editor. Oncogene. Number 21 in Issue 19. London: Nature publishing group; 2000.
147. Sehgal PB. STAT-signalling through the cytoplasmic compartment: Consideration of a new paradigm. Cell Signal 2000;12:525-535.
148. Bromberg JF. Activation of STAT proteins and growth control. BioEssays 2001;23:161-169.
149. Ihle JN. The Stat family in cytokine signaling. Curr Opin Cell Biol 2001;13:211-217.
150. Bedford MT, Leder P. The FF domain: A novel motif that often accompanies WW domains. Trends Biochem Sci 1999;24:264-265.
151. Bohne J, Cole SE, Suñe C, Lindman BR, Ko VD, Vogt TF, Garcia-Blanco MA. Expression analysis and mapping of the mouse and human transcriptional regulator CA150. Mamm Genome 2000;11:930-933.
152. Holbert S, Denghien I, Kiechle T, Rosenblatt A, Wellington C, Hayden MR, Margolis RL, Ross CA, Dausset J, Ferrante RJ, Néri C. The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: Neuropathologic and genetic evidence for a role in huntington's disease pathogenesis. Proc Natl Acad Sci USA 2001;98:1811-1816.
153. Goldstrohm AC, Albrecht TR, Suñe C, Bedford MT, Garcia-Blanco MA. The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1. Mol Cell Biol 2001;21:7617-7628.
154. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 1997;90:569-580.
155. Li H, Gomes PJ, Chen JD. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc Natl Acad Sci USA 1997;94:8479-8484.
156. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev 2001;81:1269-1304.
157. McKenna NJ, O'Malley BW. Minireview: Nuclear receptor coactivators. An update. Endocrinology 2002;143:2461-2465.
158. Heery DM, Kalkhoven E, Hoare S, Parker MG. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 1997;387:733-736.
159. Hu X, Lazar MA. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 1999;402:93-96.
160. Lee JW, Lee YC, Na SY, Jung DJ, Lee SK. Transcriptional coregulators of the nuclear receptor superfamily: Coactivators and corepressors. Cell Mol Life Sci 2001;58:289-297.
161. Andrade MA, Petosa C, O'Donoghue SI, Müller CW, Bork P. Comparison of ARM and HEAT protein repeats. J Mol Biol 2001;309:1-18.
162. Groves MR, Hanlon N, Turowski P, Hemmings BA, Barford D. The structure of the protein phosphatase 2A PR65/A subunit reveals the conformation of its 15 tandemly repeated HEAT motifs. Cell 1999;96:99-110.
163. Marcotrigiano J, Lomakin IB, Sonenberg N, Pestova TV, Hellen CU, Burley SKA. conserved HEAT domain within eIF4G directs assembly of the translation initiation machinery. Mol Cell 2001;7:193-203.
164. Mazza C, Ohno M, Segref A, Mattaj IW, Cusack S. Crystal structure of the human nuclear cap binding complex. Mol Cell 2001;8:383-396.
165. Quimby BB, Corbett AH. Nuclear transport mechanisms. Cell Mol Life Sci 2001;58:1766-1773.
166. Strom AC, Weis K. Importin-beta-like nuclear transport receptors. Genome Biol 2, 2001.
167. Macara IG. Transport into and out of the nucleus. Microbiol Mol Biol Rev 2001;65:570-594.
168. Jensen TH, Neville M, Rain JC, McCarthy T, Legrain P, Rosbash M. Identification of novel saccharomyces cerevisiae proteins with nuclear export activity: Cell cycle-regulated transcription factor Ace2p shows cell cycle-independent nucleocytoplasmic shuttling. Mol Cell Biol 2000;20:8047-8058.
169. Barker N, Clevers H. Catenins, Wnt signaling and cancer. BioEssays 2000;22:961-965.
170. Gottardi CJ, Gumbiner BM. Adhesion signaling: How beta-catenin interacts with its partners. Curr Biol 2001;11:R792-R794.
171. Sharpe C, Lawrence N, Martinez Arias A. Wnt signalling: A theme with nuclear variations. BioEssays 2001;23:311-318.
172. Pawson T, Raina M, Piers N. Interaction domains: From simple binding events to complex cellular behavior. FEBS Lett 2002;513:2-10.
173. Tait D, Riccio M, Sittler A, Scherzinger E, Santi S, Ognibene A, Maraldi NM, Lehrach H, Wanker EE. Ataxin-3 is transported into the nucleus and associates with the nuclear matrix. Hum Mol Genet 1998;7:991-997.
174. Perez MK, Paulson HL, Pittman RN. Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix. Hum Mol Genet 1999;8:2377-2385.
175. Chai Y, Wu L, Griffin JD, Paulson HL. The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease. J Biol Chem 2001;276:44889-44897.
176. McCampbell A, Taylor JP, Taye AA, Robitschek J, Li M, Walcott J, Merry D, Chai Y, Paulson H, Sobue G, Fischbeck KH. CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet 2000;9:2197-2202.
177. Zhu Q, Wani G, Wani MA, Wani AA. Human homologue of yeast Rad23 protein A interacts with p300/cyclic AMP-responsive element binding (CREB)-binding protein to down-regulate transcriptional activity of p53. Cancer Res 2001;61:64-70.
178. Demarest SJ, Martinez-Yamout M, Chung J, Chen H, Xu W, Dyson HJ, Evans RM, Wright PE. Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. Nature 2002;415:549-553.
179. Perez MK, Paulson HL, Pendse SJ, Saionz SJ, Bonini NM, Pittman RN. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J Cell Biol 1998;143:1457-1470.
180. Shimohata T, Onodera O, Tsuji S. Interaction of expanded polyglutamine stretches with nuclear transcription factors leads to aberrant transcriptional regulation in polyglutamine diseases. Neuropathology 2000;20:326-333.
181. Yamada M, Tsuji S, Takahashi H. Pathology of CAG repeat diseases. Neuropathology 2000;20:319-325.
182. McCampbell A, Fischbeck KH. Polyglutamine and CBP: Fatal attraction? Nat Med 2001;7:528-530.
183. Sterner DE, Berger SL. Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 2000;64:435-459.
184. Hughes RE. Polyglutamine disease: Acetyltransferases awry. Curr Biol 2002;12:R141-R143.
185. Gouet P, Courcelle E, Stuart DI, Métoz F. ESPript: Analysis of multiple sequence alignments in PostScript. Bioinformatics 1999;15:305-308.